Obesity rates are continuing to rise worldwide and it is inevitable that associated illnesses, such as liver disease and diabetes will follow the same trend unless new therapeutic approaches are developed.
Our programme of research explores the molecular mechanisms involved in controlling energy expenditure and fat deposition. Every day we move closer to understanding the complex processes driving human disease and closer to developing new treatments.
Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students received an unrivalled education.
At any one time, more than 1000 clinical trials are being conducted across the Cambridge Biomedical Campus, the largest gathering of clinical, pharmaceutical and biomedical research specialists in Europe. These trials are a crucial step in the design of new medicines and medical devices – translating ideas that started in a research laboratory into new treatments for patients.